Journey Medical Corporation

NASDAQ:DERM

Drug Manufacturers - Specialty & Generic

Healthcare
$3.69 +0.99%

+$0.06 today

Market cap
$104.15M
Beta
1.10
P/E (TTM)
-17.0
EPS (TTM)
-$0.35
52W Low $4.31High $9.56

Volume 0.25M

Average 0.28M

DERM Total Current Assets

All assets expected to be converted to cash or used up within one year.

Journey Medical CorporationNASDAQ: DERM

Total Current Assets · Q1 FY2026 · quarter ended Mar 2026

Total current assets rises 20.3% from a year ago

Total current assets stood at $64.97M at the end of Q1 FY2026, up 20.3% from a year earlier and down 2.9% from the prior quarter. Over 3 fiscal years it compounded at -4.9% a year.

Context

  • Total current assets amounted to 71.0% of total assets at the end of Q1 FY2026, up 7.4 pp from a year earlier.
  • Total current assets increased in 1 of the last 3 fiscal years.

What to watch

Whether total current assets keeps rising in the next quarterly balance sheet after a +20.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$64.97M-2.9% QoQ
Last fiscal yearDec 2025
$66.87M+38.8% YoY
Year agoMar 2025
$53.99M+20.3% since
Total Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.3%——
1 year+38.8%——
3-year CAGR-4.9%——
5-year CAGR——
10-year CAGR——

Total Current Assets history

USD · from the balance sheet

Latest · FY2025
66.87M USD
Year-over-year change
+38.8%
4-year CAGR
-5.7%

Total Current Assets vs competitors

How DERM compares with its peers on the latest reported figures

  • Peers report in different currencies, so total current assets is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +20.3% is the 5th highest of 10, against a peer median of +10.9%.
  • Total current assets amounts to 71.0% of total assets for DERM, versus a peer median of 63.5%.
DERM Competitors
Total Current Assets for DERM and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OGIOrganigram Global Inc.Mar 2026CA$250.73M CAD-3.0%—48.0%
IVAInventiva S.A.Dec 2025€243.84M EUR+118.7%+31.8%98.0%
OSUROraSure Technologies, Inc.Mar 2026$240.78M USD-23.3%-7.0%63.5%
RNACCartesian Therapeutics, Inc.Mar 2026$122.04M USD-34.1%-4.4%42.3%
OBIOOrchestra BioMed Holdings, Inc.Mar 2026$96.21M USD+85.4%+8.4%95.6%
FENCFennec Pharmaceuticals Inc.Mar 2026$66.88M USD+55.6%+35.5%93.1%
DERMJourney Medical CorporationMar 2026$64.97M USD+20.3%-4.9%71.0%
MDWDMediWound Ltd.Mar 2026$52.17M USD+10.9%+9.4%65.2%
NYXHNyxoah S.A.Mar 2026€40.72M EUR-45.9%-15.2%41.6%
HSDTSolana CompanyMar 2026$27.84M USD+722.4%+23.1%13.9%
Peer median (excluding DERM) —+10.9%+8.9%63.5%

Competitors are the stored peer set for DERM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents49.08M32M27.44M20.31M24.09M
Short-term Investments00000
Net Receivables23.11M28.21M15.22M10.23M29.78M
Inventory9.86M14.16M10.21M14.43M9.62M
Other Current Assets2.44M3.31M3.59M3.21M3.38M
Total Current Assets84.49M77.68M56.46M48.18M66.87M
Property, Plant & Equipment (Net)89K189K101K199K111K
Goodwill00000
Intangible Assets12.55M27.2M20.29M31.86M27.61M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets150K95K6K00
Total Non-current Assets12.79M27.48M20.39M32.06M27.72M
Total Assets97.28M105.16M76.85M80.24M94.59M
Account Payables22.81M36.98M16.08M16.05M9.31M
Short-term Debt812K2.95M3M625K0
Tax Payables8K35K53K60K70K
Deferred Revenue0053K00
Other Current Liabilities24.59M14.1M4.08M14.45M9.57M
Total Current Liabilities51.61M66.83M41.87M35.18M37.44M
Long-term Debt3.63M19.83M14.62M24.88M25.28M
Deferred Tax Liabilities8K0000
Deferred Revenue (Non-current)(8K)0000
Other Non-current Liabilities3.64M1.41M000
Total Non-current Liabilities3.64M21.35M14.63M25M25.3M
Total Liabilities55.24M88.18M56.5M60.17M62.74M
Common Stock2K2K2K2K2K
Retained Earnings(38.87M)(68.5M)(72.36M)(87.03M)(98.46M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity42.04M16.98M20.35M20.07M31.85M
Total Debt910K22.97M17.73M25.71M25.4M
Net Debt(48.17M)(9.04M)(9.71M)5.4M1.31M

Journey Medical Corporation

NASDAQ:DERM

Intrinsic Alpha fair value

Locked

Current Price

$3.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.